News Related to Montgomery-Åsberg Depression Rating Scale Score

Related coverage linked through entity extraction aliases.

DMT Shows Rapid Antidepressant Effects in Phase 2 Trial for Major Depression

Feb 23, 2026

A phase 2 trial found that a single intravenous dose of dimethyltryptamine (DMT) alongside psychotherapy significantly reduced major depressive disorder symptoms, with effects lasting up to 6 months.

Single Dose of DMT Shows Rapid Antidepressant Effects in Phase II Trial

Feb 16, 2026

A phase IIa clinical trial found that a single intravenous dose of dimethyltryptamine (DMT) with psychological support rapidly reduced depressive symptoms in 34 adults with major depressive disorder, with improvements sustained for up to three months.